Terms: = Lymphoma AND DDIT3, CHOP, 1649, ENSG00000175197, _C/EBP zeta_, MGC4154, GADD153, CHOP10, P35638 AND Treatment
3151 results:
1. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
[TBL] [Abstract] [Full Text] [Related]
3. Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy.
Sineshaw HM; Zettler CM; Prescott J; Garg M; Chakraborty S; Sarpong EM; Bai C; Belli AJ; Fernandes LL; Wang CK
Cancer Med; 2024 Apr; 13(7):e7173. PubMed ID: 38597118
[TBL] [Abstract] [Full Text] [Related]
4. Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment: A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203.
Watanabe T; Matsuno Y; Wakabayashi M; Maruyama D; Yamamoto K; Kubota N; Shimada K; Asagoe K; Yamaguchi M; Ando K; Ogura M; Kuroda J; Suehiro Y; Tsukasaki K; Tobinai K; Nagai H
Hematol Oncol; 2024 May; 42(3):e3272. PubMed ID: 38595316
[TBL] [Abstract] [Full Text] [Related]
5. Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma.
Chen J; Zhou J; Cheng F; Chen D; Guan F; Zhang E; He J; Cai Z; Zhao Y
J Cancer Res Clin Oncol; 2024 Apr; 150(4):181. PubMed ID: 38587664
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of immunochemotherapy response for diffuse large B-cell lymphoma using artificial intelligence digital pathology.
Lee JH; Song GY; Lee J; Kang SR; Moon KM; Choi YD; Shen J; Noh MG; Yang DH
J Pathol Clin Res; 2024 May; 10(3):e12370. PubMed ID: 38584594
[TBL] [Abstract] [Full Text] [Related]
7. [Successful bridging therapy with alectinib prior to allogeneic stem cell transplantation for refractory ALK-positive anaplastic large cell lymphoma].
Kono A; Tanaka K; Shimada T; Bando K; Takahata A; Koi S; Yamamoto M; Mori T; Toyota S
Rinsho Ketsueki; 2024; 65(3):158-163. PubMed ID: 38569859
[TBL] [Abstract] [Full Text] [Related]
8. Primary adrenal lymphoma presenting as neurolymphomatosis: A case report.
Chen Z; Lin L; Xu L; Lin R; Jiang X
Medicine (Baltimore); 2024 Mar; 103(12):e37558. PubMed ID: 38518055
[TBL] [Abstract] [Full Text] [Related]
9. Ferroptosis mechanisms and its novel potential therapeutic targets for DLBCL.
Bian W; Li H; Chen Y; Yu Y; Lei G; Yang X; Li S; Chen X; Li H; Yang J; Yang C; Li Y; Zhou Y
Biomed Pharmacother; 2024 Apr; 173():116386. PubMed ID: 38492438
[TBL] [Abstract] [Full Text] [Related]
10. A single-centre, real-world study of BTK inhibitors for the initial treatment of MYD88
Deng T; Zhang S; Xiao M; Gu J; Huang L; Zhou X
Cancer Med; 2024 Feb; 13(4):e7005. PubMed ID: 38457222
[TBL] [Abstract] [Full Text] [Related]
11. Primary thyroid lymphoma: a case series.
Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
[TBL] [Abstract] [Full Text] [Related]
12. Compression therapy using surgical gloves is ineffective for the prevention of vincristine-induced neuropathy in patients with malignant lymphoma.
Suyama T; Tsuboi Y; Shimizu M; Kuroda A; Seki M; Shinagawa A
Support Care Cancer; 2024 Feb; 32(3):173. PubMed ID: 38378914
[TBL] [Abstract] [Full Text] [Related]
13. Looking to achieve cure the first time around for DLBCL patients who are older and/or with co-morbidities.
Brem EA; Sehn LH
Semin Hematol; 2023 Nov; 60(5):285-290. PubMed ID: 38368147
[TBL] [Abstract] [Full Text] [Related]
14. Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases.
Furuya C; Yasuda H; Hiki M; Shirane S; Yamana T; Uchimura A; Inano T; Takaku T; Hamano Y; Ando M
Front Immunol; 2024; 15():1287300. PubMed ID: 38333218
[TBL] [Abstract] [Full Text] [Related]
15. Gastric Burkitt's monomorphic post-transplant lymphoproliferative disorder after kidney transplantation: A case report.
Yoshimura Y; Suwabe T; Fujiki A; Kaji D; Asano-Mori Y; Oba Y; Mizuno H; Yamanouchi M; Tanaka K; Hasegawa E; Miki K; Yokoyama T; Namamura Y; Ishii Y; Yamashita S; Kono K; Kinowaki K; Takazawa Y; Sawa N; Ubara Y
Clin Nephrol; 2024 May; 101(5):250-256. PubMed ID: 38329919
[TBL] [Abstract] [Full Text] [Related]
16. NOT OTHERWISE SPECIFIED T-CELL lymphoma: OUTCOMES OF A SINGLE CENTER STUDY.
Kriachok I; Tytorenko I; Shudrak N; Aleksik O; Stepanishyna Y; Kadnikova T; Pastushenko Y; Shokun N; Rudiyk T; Bushuieva M
Exp Oncol; 2024 Feb; 45(4):474-482. PubMed ID: 38328842
[TBL] [Abstract] [Full Text] [Related]
17. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received chop or R-chop.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
18. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
[TBL] [Abstract] [Full Text] [Related]
19. Navigating between Scylla and Charybdis: A roadmap to do better than Pola-RCHP in DLBCL.
Munoz J; Deshpande A; Rimsza L; Nowakowski GS; Kurzrock R
Cancer Treat Rev; 2024 Mar; 124():102691. PubMed ID: 38310754
[TBL] [Abstract] [Full Text] [Related]
20. High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-chop.
Dhar S; Chakravarti M; Ganguly N; Saha A; Dasgupta S; Bera S; Sarkar A; Roy K; Das J; Bhuniya A; Ghosh S; Sarkar M; Hajra S; Banerjee S; Pal C; Saha B; Mukherjee KK; Baral R; Bose A
Front Immunol; 2023; 14():1303959. PubMed ID: 38304256
[TBL] [Abstract] [Full Text] [Related]
[Next]